Skip to main content

Table 1 Patients’ demographic and clinical characteristics

From: Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma

Prognostic variables No. Proportion(%)
Gender
 Male 45 69.23
 Female 20 30.77
Clinical stage
 I 14 21.54
 II 20 30.77
 III 13 20.00
 IV 18 27.69
B symptoms
 With 26 40.00
 Without 39 60.00
IPI Scores
 1 22 33.85
 2 24 36.92
 3 14 21.54
 4 5 7.69
Final Recurrence status
 With 9 13.85
 Without 56 86.15
Ki67 index
 Low 33 50.77
 High 32 49.23